SCHEMBL13422

SCHEMBL13422

O=S1(=O)CCNCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Piperazine SCHEMBL7529697 0.96 HIF1A (0.43)
Hydrochloric Acid SCHEMBL4261800 0.96 HIF1A (0.33)
Hydrochloric Acid SCHEMBL1002624 0.96
Methane SCHEMBL28109159 0.96
Water SCHEMBL28235026 0.96
SCHEMBL2621589 0.87
SCHEMBL20523142 0.86 HIF1A (0.31)
Hydrochloric Acid SCHEMBL18817103 0.85 CXCR4 (0.35)
SCHEMBL3711641 0.85
Formic Acid SCHEMBL30170635 0.85

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 19980 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4105216-B1 DIHYDRONAPHTHYRIDINONE COMPOUND, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF GENFLEET THERAPEUTICS SHANGHAI INC (CN) 2026-05-20 EP claimed
WO-2026077418-A9 ISOINDOLINE COMPOUND CONTAINING PHENYLETHOXYALKYLENEAMINE STRUCTURE, CONJUGATE THEREOF, AND USE THEREOF 上海海雁医药科技有限公司 2026-05-15 WO claimed
EP-4739682-A1 1,6-NAPHTHRIDINE COMPOUNDS AS SMARCA2 INHIBITORS USEFUL FOR THE TREATMENT OF SMARCA4 DEFICIENT CANCERS Janssen Pharmaceutica NV (BE) 2026-05-13 EP claimed
EP-4041730-B1 SUBSTITUTED BICYCLIC HETEROARYL COMPOUNDS BRISTOL MYERS SQUIBB CO (US) 2026-05-13 EP claimed
US-20260109677-A1 COMPOUNDS, DEVICES, AND USES THEREOF SIGILON THERAPEUTICS INC (US) 2026-04-23 US claimed
US-20260103459-A1 SUBSTITUTED AZACYLES AS TRPM8 MODULATORS GIVAUDAN SA (CH) 2026-04-16 US claimed
EP-4705300-A1 PYRIDO[4,3-D]PYRIMIDINE DERIVATIVES AS MUTANT KRAS G12C INHIBITORS FOR THE TREATMENT OF CANCER Frontier Medicines Corporation (US) 2026-03-11 EP claimed
CN-121586713-A Quinoline derivatives and pharmaceutical compositions thereof for the treatment of diseases 百济神州(苏州)生物科技有限公司 2026-02-27 CN claimed
US-12528801-B2 Substituted azacyles as TRPM8 modulators GIVAUDAN SA (CH) 2026-01-20 US claimed
EP-4678626-A1 LONG-CHAIN ALKENYLOXY-SUBSTITUTED BENZOYL DERIVATIVE AND OLIGONUCLEOTIDE SYNTHESIS METHOD USING SAME Spera Pharma, Inc. (JP) 2026-01-14 EP claimed
US-4388315-A TAUTOMERIC PYRIMIDINE DERIVATIVES BOEHRINGER INGELEHEIM GMBH (DE) 1983-06-14 US claimed
EP-0078668-A1 Preparation of aminocyclopentanealkenoic acids GLAXO GROUP LIMITED (GB) 1983-05-11 EP claimed
US-4371530-A INTIOCOAGULANTS, BRONCHODILATORS GLAXO GROUP LIMITED (GB) 1983-02-01 US claimed
US-4265891-A PROSTAGLANDINS, BRONCHODILATORS, PLATELET AGGREGATION INHIBITORS GLAXO GROUP LIMITED (GB) 1981-05-05 US claimed
US-4241056-A ANTIBIOTICS BOEHRINGER INGELHEIM GMBH (DE) 1980-12-23 US claimed
US-4211867-A ANTISECRETORY AGENTS, HYPOGLYCEMIC AGENTS, ANTIARRHYTHMIA AGENTS MCNEIL LABORATORIES, INCORPORATED (US) 1980-07-08 US claimed
US-4061751-A 6-Substituted 3-nitroimidazo[1,2-b]pyridazine for the control of foot rot and liver lesions in ruminant animals AMERICAN CYANAMID COMPANY (US) 1977-12-06 US claimed
US-4060614-A 6-Substituted 3-nitroimidazo[1,2-b]pyridazine for the control of hemorrhagic colitis in swine AMERICAN CYANAMID COMPANY (US) 1977-11-29 US claimed
US-3997665-A QUINOXALINE DIOXIDES BAYER AKTIENGESELLSCHAFT (DT) 1976-12-14 US claimed
US-3951963-A 0-(Substituted-aminoalkyl)-5-nitroimidazole-(2)-aldoximes HOECHST AKTIENGESELLSCHAFT (DT) 1976-04-20 US claimed